Trametinib in combination with dabrafenib for treating unresectable or metastatic melanoma

Technology appraisal guidance
Reference number: TA396
Published: 22 June 2016

Evidence

Supporting evidence

Review decision
Review decision – October 2020
Review decision paper (PDF 152 KB)

Published:

09 October 2020